Outlook 2025

Products & Care

• The pharmacy network is being continuously optimised and reinforced by means of acquisitions, including through investments in the shopfitting and consultation concept at physical points of sale.
• Roll-out of the Prescription Manager in all Galenica pharmacies. The digital helper supports people who need medication regularly and have to extend their repeat prescriptions.
• The online presence of Galenica pharmacies will be further developed and strengthened as an important part of the Omni-Channel strategy. In addition to an improved online shopping experience, the focus is on providing knowledge about health and well-being and the opportunity to make appointments for consultations and services.
• The importance of the pharmacy as the first point of contact for health issues is to be developed further. This includes easy customer access to advisory and service offerings and a service portfolio tailored to customer needs. In addition, Galenica is committed to ensuring that the advice and services provided in pharmacies are reimbursed by other health insurers.
• In the home care and care home sector, the collaboration between Bichsel, Mediservice, Medifilm, Lifestage Solutions and Emeda will be further expanded and the applications established with customers will be combined.
• Cooper Consumer Health and Verfora Ltd. are intensifying their partnership. From 1 January 2025, Verfora Ltd. will be distributing the former Viatris OTC products, which were taken over by Cooper Consumer Health.

Logistics & IT

• Following the successful pilot projects, the electronic prescription is to be implemented as a new standard for service providers. Galenica is also actively participating in developing and implementing national standards.
• The Documedis^® software solution from HCI Solutions is to be introduced to more doctors, care homes and hospitals. Documedis^® supports service providers in making decisions (clinical decision support) and makes an important contribution to increasing patient safety.
• HCI Solutions lodged an appeal with the Federal Administrative Court against a ruling by the Swiss Competition Commission (COMCO) in 2017. In line with practice, the COMCO demanded payment of the sanction in the amount of CHF 3.8 million and the costs of the proceedings once the Federal Administrative Court's decision was available. In January 2025, the Federal Supreme Court ruled largely in favour of HCI Solutions and referred the case to the Federal Administrative Court for a new determination of the sanction and the procedural costs incurred by the previous instance. Galenica expects that the new sanction will be significantly reduced or not imposed at all. The resulting income is not reflected in the EBIT guidance for 2025.
• The implementation of the defined measures for achieving the sustainability goals is also a top priority. For example, further pilot projects with alternative drives for delivery vehicles are to be launched and the necessary charging infrastructure for company vehicles is to be set up at relevant locations.
• The ERP replacement at the Galexis site in Lausanne-Ecublens in spring 2025 will enable the product range to be expanded. As a result, more products will be available more quickly in French-speaking Switzerland in the future. In addition, picking productivity can be increased.
• In the doctor’s segment, even more customers should benefit from the DispoCura ordering interface and thus be able to increase efficiency in medical practices. The range of laboratory analyses in practices is also being expanded.

¹⁾ Excluding the effects of IAS 19 and IFRS 16.